Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome

Chen Yang, Cheng Hung Huang, Mei Leng Cheong, Kun Long Hung, Lung Huang Lin, Yeong Seng Yu, Chih Cheng Chien, Huei Chen Huang, Chan Wei Chen, Chi Jung Huang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Chromosome 22q11 deletion syndrome (22q11DS) causes a developmental disorder during the embryonic stage, usually because of hemizygous deletions. The clinical pictures of patients with 22q11DS vary because of polymorphisms: on average, approximately 93% of affected individuals have a de novo deletion of 22q11, and the rest have inherited the same deletion from a parent. Methods using multiple genetic markers are thus important for the accurate detection of these microdeletions. Methods: We studied 12 babies suspected to carry 22q11DS and 18 age-matched healthy controls from unrelated Taiwanese families. We determined genomic variance using microarray-based comparative genomic hybridization (array-CGH), quantitative real-time polymerase chain reaction (qPCR) and multiplex ligation-dependent probe amplification (MLPA). Results: Changes in genomic copy number were significantly associated with clinical manifestations for the classical criteria of 22q11DS using MPLA and qPCR (p <0.01). An identical deletion was shown in three affected infants by MLPA. These reduced DNA dosages were also obtained partially using array-CGH and confirmed by qPCR but with some differences in deletion size. Conclusion: Both MLPA and qPCR could produce a clearly defined range of deleted genomic DNA, whereas there must be a deleted genome that is not distinguishable using MLPA. These data demonstrate that such multiple genetic approaches are necessary for the unambiguous molecular detection of these types of complicated genomic syndromes.

Original languageEnglish
Article number16
JournalBMC Medical Genetics
Volume10
DOIs
Publication statusPublished - 2009

Fingerprint

22q11 Deletion Syndrome
Chromosome Deletion
Multiplex Polymerase Chain Reaction
Real-Time Polymerase Chain Reaction
Comparative Genomic Hybridization
DNA
Genetic Markers
Genome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome. / Yang, Chen; Huang, Cheng Hung; Cheong, Mei Leng; Hung, Kun Long; Lin, Lung Huang; Yu, Yeong Seng; Chien, Chih Cheng; Huang, Huei Chen; Chen, Chan Wei; Huang, Chi Jung.

In: BMC Medical Genetics, Vol. 10, 16, 2009.

Research output: Contribution to journalArticle

Yang, Chen ; Huang, Cheng Hung ; Cheong, Mei Leng ; Hung, Kun Long ; Lin, Lung Huang ; Yu, Yeong Seng ; Chien, Chih Cheng ; Huang, Huei Chen ; Chen, Chan Wei ; Huang, Chi Jung. / Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome. In: BMC Medical Genetics. 2009 ; Vol. 10.
@article{64d710327a0c4471842201f1f88d9651,
title = "Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome",
abstract = "Background: Chromosome 22q11 deletion syndrome (22q11DS) causes a developmental disorder during the embryonic stage, usually because of hemizygous deletions. The clinical pictures of patients with 22q11DS vary because of polymorphisms: on average, approximately 93{\%} of affected individuals have a de novo deletion of 22q11, and the rest have inherited the same deletion from a parent. Methods using multiple genetic markers are thus important for the accurate detection of these microdeletions. Methods: We studied 12 babies suspected to carry 22q11DS and 18 age-matched healthy controls from unrelated Taiwanese families. We determined genomic variance using microarray-based comparative genomic hybridization (array-CGH), quantitative real-time polymerase chain reaction (qPCR) and multiplex ligation-dependent probe amplification (MLPA). Results: Changes in genomic copy number were significantly associated with clinical manifestations for the classical criteria of 22q11DS using MPLA and qPCR (p <0.01). An identical deletion was shown in three affected infants by MLPA. These reduced DNA dosages were also obtained partially using array-CGH and confirmed by qPCR but with some differences in deletion size. Conclusion: Both MLPA and qPCR could produce a clearly defined range of deleted genomic DNA, whereas there must be a deleted genome that is not distinguishable using MLPA. These data demonstrate that such multiple genetic approaches are necessary for the unambiguous molecular detection of these types of complicated genomic syndromes.",
author = "Chen Yang and Huang, {Cheng Hung} and Cheong, {Mei Leng} and Hung, {Kun Long} and Lin, {Lung Huang} and Yu, {Yeong Seng} and Chien, {Chih Cheng} and Huang, {Huei Chen} and Chen, {Chan Wei} and Huang, {Chi Jung}",
year = "2009",
doi = "10.1186/1471-2350-10-16",
language = "English",
volume = "10",
journal = "BMC Medical Genetics",
issn = "1471-2350",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome

AU - Yang, Chen

AU - Huang, Cheng Hung

AU - Cheong, Mei Leng

AU - Hung, Kun Long

AU - Lin, Lung Huang

AU - Yu, Yeong Seng

AU - Chien, Chih Cheng

AU - Huang, Huei Chen

AU - Chen, Chan Wei

AU - Huang, Chi Jung

PY - 2009

Y1 - 2009

N2 - Background: Chromosome 22q11 deletion syndrome (22q11DS) causes a developmental disorder during the embryonic stage, usually because of hemizygous deletions. The clinical pictures of patients with 22q11DS vary because of polymorphisms: on average, approximately 93% of affected individuals have a de novo deletion of 22q11, and the rest have inherited the same deletion from a parent. Methods using multiple genetic markers are thus important for the accurate detection of these microdeletions. Methods: We studied 12 babies suspected to carry 22q11DS and 18 age-matched healthy controls from unrelated Taiwanese families. We determined genomic variance using microarray-based comparative genomic hybridization (array-CGH), quantitative real-time polymerase chain reaction (qPCR) and multiplex ligation-dependent probe amplification (MLPA). Results: Changes in genomic copy number were significantly associated with clinical manifestations for the classical criteria of 22q11DS using MPLA and qPCR (p <0.01). An identical deletion was shown in three affected infants by MLPA. These reduced DNA dosages were also obtained partially using array-CGH and confirmed by qPCR but with some differences in deletion size. Conclusion: Both MLPA and qPCR could produce a clearly defined range of deleted genomic DNA, whereas there must be a deleted genome that is not distinguishable using MLPA. These data demonstrate that such multiple genetic approaches are necessary for the unambiguous molecular detection of these types of complicated genomic syndromes.

AB - Background: Chromosome 22q11 deletion syndrome (22q11DS) causes a developmental disorder during the embryonic stage, usually because of hemizygous deletions. The clinical pictures of patients with 22q11DS vary because of polymorphisms: on average, approximately 93% of affected individuals have a de novo deletion of 22q11, and the rest have inherited the same deletion from a parent. Methods using multiple genetic markers are thus important for the accurate detection of these microdeletions. Methods: We studied 12 babies suspected to carry 22q11DS and 18 age-matched healthy controls from unrelated Taiwanese families. We determined genomic variance using microarray-based comparative genomic hybridization (array-CGH), quantitative real-time polymerase chain reaction (qPCR) and multiplex ligation-dependent probe amplification (MLPA). Results: Changes in genomic copy number were significantly associated with clinical manifestations for the classical criteria of 22q11DS using MPLA and qPCR (p <0.01). An identical deletion was shown in three affected infants by MLPA. These reduced DNA dosages were also obtained partially using array-CGH and confirmed by qPCR but with some differences in deletion size. Conclusion: Both MLPA and qPCR could produce a clearly defined range of deleted genomic DNA, whereas there must be a deleted genome that is not distinguishable using MLPA. These data demonstrate that such multiple genetic approaches are necessary for the unambiguous molecular detection of these types of complicated genomic syndromes.

UR - http://www.scopus.com/inward/record.url?scp=62349084378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62349084378&partnerID=8YFLogxK

U2 - 10.1186/1471-2350-10-16

DO - 10.1186/1471-2350-10-16

M3 - Article

C2 - 19243607

AN - SCOPUS:62349084378

VL - 10

JO - BMC Medical Genetics

JF - BMC Medical Genetics

SN - 1471-2350

M1 - 16

ER -